Aehr Test Systems (NASDAQ:AEHR – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.
Separately, Craig Hallum raised shares of Aehr Test Systems from a “hold” rating to a “buy” rating and increased their price objective for the stock from $12.00 to $25.00 in a research report on Wednesday, July 17th.
Read Our Latest Research Report on Aehr Test Systems
Aehr Test Systems Price Performance
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last announced its earnings results on Friday, July 19th. The semiconductor company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.70. The firm had revenue of $16.60 million for the quarter. Aehr Test Systems had a net margin of 50.07% and a return on equity of 39.32%. During the same quarter in the prior year, the company posted $0.21 earnings per share. Equities analysts anticipate that Aehr Test Systems will post 0.25 EPS for the current fiscal year.
Institutional Trading of Aehr Test Systems
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AEHR. Price T Rowe Associates Inc. MD grew its stake in Aehr Test Systems by 6.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,018 shares of the semiconductor company’s stock worth $199,000 after acquiring an additional 961 shares in the last quarter. RiverPark Advisors LLC boosted its stake in shares of Aehr Test Systems by 360.8% during the first quarter. RiverPark Advisors LLC now owns 2,069 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 1,620 shares in the last quarter. Greenwood Capital Associates LLC boosted its stake in shares of Aehr Test Systems by 10.6% during the fourth quarter. Greenwood Capital Associates LLC now owns 21,046 shares of the semiconductor company’s stock valued at $558,000 after purchasing an additional 2,023 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in shares of Aehr Test Systems during the fourth quarter valued at approximately $73,000. Finally, Stratos Wealth Partners LTD. boosted its stake in shares of Aehr Test Systems by 19.3% during the fourth quarter. Stratos Wealth Partners LTD. now owns 20,805 shares of the semiconductor company’s stock valued at $552,000 after purchasing an additional 3,368 shares in the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.
Aehr Test Systems Company Profile
Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.
Featured Articles
- Five stocks we like better than Aehr Test Systems
- Industrial Products Stocks Investing
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Stock Dividend Cuts Happen Are You Ready?
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Canada Bond Market Holiday: How to Invest and Trade
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.